Clinical Trial Update: Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache [Phase 4]

View source ↗

Summary

A Phase 4 randomized, placebo-controlled trial evaluating etoricoxib to prevent Yom Kippur headache.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Headache | Phase 4 | Status: UNKNOWN